Leukemia
Central Hospital Reports Research in Leukemia
Published in Surgery Litigation and Law Weekly, June 24th, 2011
2011 JUN 24 -- Current study results from the report, "Oral pigmentation in the hard palate associated with imatinib mesylate therapy: a report of three cases," have been published. "Imatinib mesylate is a tyrosine kinase inhibitor which targets Bcr-Abl-protein, c-Kit, and platelet-derived growth factor receptor. The drug was originally developed for treatment of chronic myeloid leukemia but is also regarded as first-line treatment of patients with metastatic gastrointestinal stromal tumours (GIST)," scientists writing in the journal Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics report.
"Dermatologic side effects are...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- Osteoporosis
Bariatric surgery linked to increased fracture risk - Biotechnology
Bye Bye Stretch Marks, Acne Scars, Hypigmentation and Sun Damaged Skin With No Downtime, Surgery or Repeated Ablative Burns - Clinical Trials Research
City of Hope researchers to present rectal cancer, palliative care, benchmarking studies at ASCO - Orthopedics
Columbia University Reports Research in Orthopedics - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
